Clinical trial
Microvesicles and Monocytes to Predict Mortality of Patients with Cirrhosis
NCT03837444 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microvesicles and Monocytes to Predict Mortality of Patients with Cirrhosis
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 12, 2019
- Completion date
- February 29, 2024
- Enrollment
- 335 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
cirrhosis